Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D)... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
GUTS is expected to report earnings to fall 17.19% to -159 cents per share on November 12
Q3'26
Est.
$-1.59
Q2'26
Beat
by $1.08
Q1'26
Beat
by $0.19
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.29
The last earnings report on August 10 showed earnings per share of -191 cents, beating the estimate of -300 cents. With 90.22K shares outstanding, the current market capitalization sits at 148.01M.